Vinpocetine structure
|
Common Name | Vinpocetine | ||
|---|---|---|---|---|
| CAS Number | 42971-09-5 | Molecular Weight | 350.454 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 419.5±45.0 °C at 760 mmHg | |
| Molecular Formula | C22H26N2O2 | Melting Point | 147-153ºC dec | |
| MSDS | Chinese USA | Flash Point | 207.5±28.7 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of VinpocetineVinpocetine(Cavinton; Ethyl apovincaminate) is a selective for PDE1 (IC50 = 21 μM). Also blocks voltage-gated Na+ channels.IC50 value:Target: PDE1; Na+ channel |
| Name | Vinpocetine |
|---|---|
| Synonym | More Synonyms |
| Description | Vinpocetine(Cavinton; Ethyl apovincaminate) is a selective for PDE1 (IC50 = 21 μM). Also blocks voltage-gated Na+ channels.IC50 value:Target: PDE1; Na+ channel |
|---|---|
| Related Catalog | |
| References |
[1]. Patyar S, et al. Role of vinpocetine in cerebrovascular diseases.Pharmacol Rep. 2011;63(3):618-28. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 419.5±45.0 °C at 760 mmHg |
| Melting Point | 147-153ºC dec |
| Molecular Formula | C22H26N2O2 |
| Molecular Weight | 350.454 |
| Flash Point | 207.5±28.7 °C |
| Exact Mass | 350.199432 |
| PSA | 34.47000 |
| LogP | 5.14 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.666 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Precautionary Statements | P301 + P312 + P330 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn:Harmful |
| Risk Phrases | R22 |
| Safety Phrases | S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | JW4792000 |
| HS Code | 2933990090 |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Vinpocetine and α-tocopherol prevent the increase in DA and oxidative stress induced by 3-NPA in striatum isolated nerve endings.
J. Neurochem. 124(2) , 233-40, (2013) Vinpocetine is a neuroprotective drug that exerts beneficial effects on neurological symptoms and cerebrovascular disease. 3-nitropropionic acid (3-NPA) is a toxin that irreversibly inhibits succinate... |
|
|
[Current possibilities of the correction of oxidative stress in acute brain ischaemia].
Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova 112(11) , 79-82, (2012)
|
|
|
Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats.
Indian J. Pharmacol. 44(6) , 774-9, (2012) To evaluate the neuroprotective effect of the nootropic drugs, piracetam (PIR) and vinpocetine (VIN), in rotenone-induced Parkinsonism in rats.Sixty male rats were divided into 6 groups of 10 rats eac... |
| EINECS 256-028-0 |
| (3α,16α)-Eburnamenine-14-carboxylic acid ethyl ester |
| vinpocetine |
| MFCD00211233 |
| Eburnamenine-14-carboxylic acid ethyl ester |